Diovan (Valsartan) - Reports of Side Effects and Adverse Reactions

Rx drug information, pharmaceutical research, clinical trials, news, and more

Drugs by Name

Drugs by Condition

Drugs by Category

Alerts

Diovan Rx

Summary Description and Clinical Pharmacology Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Other Rx Information Active Ingredients Adverse Event Reports User Ratings / Reviews

Diovan News

News in Media Published Studies Curr't Clinical Trials

Index of reports > Cases resulting in life threatening events (51)

Blood Lactate Dehydrogenase Increased (18), Alanine Aminotransferase Increased (12), White Blood Cell Count Increased (12), Pyrexia (8), Blood Alkaline Phosphatase Increased (7), Dyspnoea (7), Vomiting (7), Haemoglobin Decreased (7), Aspartate Aminotransferase Increased (7), Haematocrit Decreased (6)

Below is the selection of adverse event reports related to Diovan (Valsartan) that includes cases resulting in life threatening events.

Reports 1 - 25 of 51 Next >>

Adverse event in 35 year old male receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-31

Patient: 35 year old male, weighing 87.0 kg (191.4 pounds)

Adverse reactions / side effects: Alcohol USE, Vomiting, Hypopnoea, Multiple Drug Overdose Intentional, Suicide Attempt, Self-Medication, Shock

Adverse event resulted in: life threatening event

Suspect drug(s):
Adalat CR (Nifedipine) (Tablet) (Nifedipine)
    Dosage: 48t (1920 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Allopurinol
    Dosage: 32t (3200 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Artist (Carvedilol) (Tablet) (Carvedilol)
    Dosage: 32t (320 mg, 1 in1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Diovan
    Dosage: 8t (320 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Olmesartan Medoxomil
    Dosage: 74t (1480 mg, 1 in 1 d) per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Adverse event in 35 year old male receiving Diovan (Valsartan)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-30

Patient: 35 year old male

Adverse reactions / side effects: Blood Alkaline Phosphatase Decreased, Vomiting, Blood Lactate Dehydrogenase Increased, Paralysis, Overdose, Fibrin Increased, Shock, White Blood Cell Count Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Adalat
    Dosage: oral
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Allopurinol
    Dosage: oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Carvedilol
    Dosage: oral
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Diovan
    Dosage: oral
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Olmesartan Medoxomil
    Dosage: oral
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Adverse event in 81 year old female receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-10-24

Patient: 81 year old female, weighing 48.0 kg (105.6 pounds)

Adverse reactions / side effects: Gallbladder Cancer, Cerebral Infarction

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Diovan (Valsartan)

Adverse event in 73 year old male receiving Diovan (Valsartan)

Reported by a physician on 2007-10-22

Patient: 73 year old male

Adverse reactions / side effects: White Blood Cell Count Decreased, Agranulocytosis, C-Reactive Protein Increased, Pyrexia, Neutrophil Count Decreased

Adverse event resulted in: life threatening event

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Lasix

Adverse event in 35 year old male receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-19

Patient: 35 year old male

Adverse reactions / side effects: Blood Alkaline Phosphatase Decreased, Vomiting, Hypotension, Blood Lactate Dehydrogenase Increased, Paralysis, Gastrointestinal Tube Insertion, Respiratory Rate Decreased, Overdose, Heart Rate Decreased, White Blood Cell Count Increased, Shock, Fibrin Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Adalat
    Dosage: 40 mg x 40 tablets
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Allopurinol
    Dosage: 100 mg x 32 tablets
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Carvedilol
    Dosage: 10 mg x 32 tablets
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Diovan
    Dosage: 40mgx 8 tablets
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Olmetec
    Dosage: 20 mg x 74 tablets
    Administration route: Oral
    Start date: 2007-08-18
    End date: 2007-08-18

Other drugs received by patient: Alcohol

Adverse event in 77 year old female receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from United States on 2007-10-18

Patient: 77 year old female, weighing 67.6 kg (148.7 pounds)

Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Gastrointestinal Haemorrhage, Autoimmune Hepatitis, Blood Albumin Decreased, Bloody Airway Discharge, Oedema Peripheral, Paracentesis, Blood Test Abnormal, Hepatic Cirrhosis, Iron Binding Capacity Total Decreased, Blood Alkaline Phosphatase Increased, Biliary Fibrosis, Bursitis, Tremor, Aspartate Aminotransferase Increased, Cholecystectomy, Portal Hypertension, Jaundice, Acid Fast Stain Positive, Dyslipidaemia, General Physical Condition Abnormal, Brain Natriuretic Peptide Decreased, Blood Thyroid Stimulating Hormone Abnormal, Disease Progression, Hepatitis B Antibody Abnormal, International Normalised Ratio Decreased, Blood Bilirubin Abnormal, Pleural Effusion, Oedema, Abdominal Distension, Gastrooesophageal Reflux Disease, Decreased Appetite, Dyspnoea, Cataract, Vomiting, Alanine Aminotransferase Increased, Biopsy Liver Abnormal, Ascites, Hepatic Enzyme Increased, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Ranitidine HCL; Allegra; Fosamax; Calcium; Atarax; Ambien; Lasix; Librium; Imuran; Prednisone; Aldactone; Aldactone; Lactulose; Esomeprazole; Stool Softener

Adverse event in 35 year old male receiving Diovan (Valsartan)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-09

Patient: 35 year old male

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Adalat
    Dosage: 1920mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Allopurinol
    Dosage: 32000mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Artist
    Dosage: 320mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Diovan
    Dosage: 320mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Olmetec
    Dosage: 1480mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Adverse event in 35 year old male receiving Diovan (Valsartan)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-09

Patient: 35 year old male

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Adalat
    Dosage: 1920mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Allopurinol
    Dosage: 32000mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Artist
    Dosage: 320mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Diovan
    Dosage: 320mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Olmetec
    Dosage: 1480mg per day
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Adverse event in 35 year old male receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-04

Patient: 35 year old male, weighing 87.0 kg (191.4 pounds)

Adverse reactions / side effects: Vomiting, Overdose, Suicide Attempt, Shock, Mobility Decreased

Adverse event resulted in: life threatening event

Allopurinol
    Dosage: 32t (3200 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Artist (Carvedilol) (Tablet) (Carvedilol)
    Dosage: 32t (320 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Diovan
    Dosage: 8t (320 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Olmesartan Medoxomil
    Dosage: 74t (1480 mg, 1 in 1 d), per oral
    Administration route: Oral
    Indication: Self Mutilation
    Start date: 2007-08-18
    End date: 2007-08-18

Adverse event in 91 year old female receiving Diovan (Valsartan)

Reported by a physician from United States on 2007-10-02

Patient: 91 year old female

Adverse reactions / side effects: Malaise, Gastrointestinal Haemorrhage, Gastric Operation, Gastric Cancer

Adverse event resulted in: life threatening event

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Norvasc; Glucotrol XL; Triamterene and Hydrochlorothiazid ^harris^; Fosamax; Celebrex

Adverse event in 72 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-10-02

Patient: 72 year old male

Adverse reactions / side effects: Lung Neoplasm Malignant

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2003-05-26
    End date: 2004-05-18

Diovan
    Dosage: 120 mg, qd
    Administration route: Oral
    Start date: 2004-05-19
    End date: 2004-11-10

Diovan
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2004-11-11
    End date: 2006-01-19

Other drugs received by patient: Cabergoline; Madopar

Adverse event in 78 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-26

Patient: 78 year old male, weighing 52.0 kg (114.4 pounds)

Adverse reactions / side effects: Jaundice, Eosinophil Count Decreased, Blood Bilirubin Increased, Nasopharyngitis, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Liver Disorder, Weight Increased, Haemoglobin Decreased, Haematocrit Decreased, Malaise, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Aspartate Aminotransferase Increased, Peritoneal Effusion

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan
    Dosage: 40 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-11-01

Flomox
    Dosage: 300 mg/day
    Administration route: Oral
    Indication: Upper Respiratory Tract Inflammation
    Start date: 2007-05-21
    End date: 2007-05-25

Kakkon-TO
    Dosage: 7.5 g/day
    Administration route: Oral
    Indication: Upper Respiratory Tract Inflammation
    Start date: 2007-05-21
    End date: 2007-05-25

Adverse event in 84 year old female receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-25

Patient: 84 year old female, weighing 38.0 kg (83.6 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Purpura, Eosinophilia, Cholelithiasis, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Thrombocytopenia, Bilirubin Conjugated Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Spiriva; Frandol

Adverse event in 78 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-24

Patient: 78 year old male, weighing 52.0 kg (114.4 pounds)

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan
    Dosage: 40 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-11-01

Flomox
    Dosage: 300 mg/day
    Administration route: Oral
    Indication: Upper Respiratory Tract Inflammation
    Start date: 2007-05-21
    End date: 2007-05-25

Kakkon-TO
    Dosage: 7.5 g/day
    Administration route: Oral
    Indication: Upper Respiratory Tract Inflammation
    Start date: 2007-05-21
    End date: 2007-05-25

Adverse event in 82 year old male receiving Diovan (Valsartan)

Reported by a pharmacist from Japan on 2007-07-23

Patient: 82 year old male

Adverse reactions / side effects: Interstitial Lung Disease, Pyrexia, Computerised Tomogram Abnormal

Adverse event resulted in: life threatening event

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Bufferin; Pravastatin Sodium; Magmitt; Artist

Adverse event in 87 year old female receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-23

Patient: 87 year old female, weighing 35.0 kg (77.0 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Coagulopathy, Cholestasis, Coma, Hepatic Failure, Gastrointestinal Tube Insertion, Liver Disorder, Hepatic Encephalopathy, Subdural Haematoma, Malaise, Gamma-Glutamyltransferase Increased, Cholecystitis, Gallbladder Disorder, Prothrombin Time Ratio Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Tremor, Cholelithiasis, Anorexia, Aspartate Aminotransferase Increased, Gallbladder Polyp

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Amaryl
    Dosage: 1 mg/day
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-04-01
    End date: 2007-05-17

Aspirin
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2007-04-01
    End date: 2007-05-26

Diovan
    Dosage: 40 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-06-14
    End date: 2007-05-23

Norvasc
    Dosage: 2.5 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 1999-05-01
    End date: 2007-05-25

Other drugs received by patient: Roxatidine Acetate HCL; Nateglinide; Triazolam; Lisinopril; Lisinopril

Adverse event in male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-20

Patient: male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Pneumonia, Disseminated Intravascular Coagulation, Toxic Epidermal Necrolysis, Pancytopenia, Liver Disorder

Adverse event resulted in: life threatening event

Suspect drug(s):
Amlodipine
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2004-05-01
    End date: 2007-06-20

Aspirin
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2006-07-20
    End date: 2007-06-20

Diovan
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-08-30
    End date: 2007-06-20

Famotidine
    Indication: Gastric Ulcer
    Start date: 2007-06-17
    End date: 2007-06-25

Omeprazole
    Administration route: Oral
    Indication: Gastric Ulcer
    Start date: 2007-06-08
    End date: 2007-06-17

Omeprazole
Start date: 2007-05-30
End date: 2007-06-07

Rabeprazole Sodium
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2006-07-20
    End date: 2007-06-20

Rhythmy
    Administration route: Oral
    Indication: Insomnia
    Start date: 2004-01-01
    End date: 2007-06-20

Sigmart
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2004-08-30
    End date: 2007-06-20

Simvastatin
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2004-11-02
    End date: 2007-06-20

Ticlopidine HCL
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2006-07-20
    End date: 2007-06-20

Other drugs received by patient: Vitamedin

Adverse event in 56 year old female receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from United States on 2007-07-17

Patient: 56 year old female

Adverse reactions / side effects: Dyspnoea, Chest Discomfort, Pain in Extremity, Skin Exfoliation, Abasia, DRY Skin, Stress, Hyperhidrosis, Arthralgia, Thyroidectomy, Insomnia, Alopecia, Thyroid Disorder, Gait Disturbance, Arthritis

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Fluoxetine

Adverse event in 66 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-13

Patient: 66 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Ventricular Tachycardia, Wolff-Parkinson-White Syndrome, Atrial Fibrillation, Cardiogenic Shock

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan (Valsartan)

Adverse event in female receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from United States on 2007-07-11

Patient: female, weighing 90.7 kg (199.6 pounds)

Adverse reactions / side effects: Drug Dose Omission, Asthma, DRY Skin, Hypoaesthesia, Fatigue, Arthralgia, Oedema Peripheral, Insomnia, Hypothyroidism, Bronchitis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan (Valsartan)

Adverse event in 80 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-10

Patient: 80 year old male, weighing 52.0 kg (114.4 pounds)

Adverse reactions / side effects: Pyrexia, Haematocrit Decreased, RED Blood Cell Count Decreased, Fracture, Bone Marrow Failure, Blood Creatinine Increased, Blood Sodium Decreased, Lymphocyte Count Decreased, White Blood Cell Count Decreased, Blood Urea Increased, Urinary Tract Infection, Eosinophil Count Increased, Haemoglobin Decreased, Basophil Count Increased, Renal Failure, Blood Potassium Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-02-01
    End date: 2002-02-19

Diovan
    Dosage: 40 mg/day
    Administration route: Oral
    Start date: 2002-02-20
    End date: 2002-02-26

Diovan
    Dosage: 20 mg/day
    Administration route: Oral
    Start date: 2002-02-27
    End date: 2003-04-14

Diovan
    Dosage: 80 mg/day
    Administration route: Oral
    Start date: 2003-04-15
    End date: 2004-09-15

Diovan
    Dosage: 120 mg/day
    Administration route: Oral
    Start date: 2004-09-16
    End date: 2006-08-31

Diovan
    Dosage: 160 mg/day
    Administration route: Oral
    Start date: 2006-09-01
    End date: 2007-03-09

Diovan
    Dosage: 40 mg/day
    Administration route: Oral
    Start date: 2007-04-03
    End date: 2007-04-10

Fosmicin
    Dosage: 1000 mg/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2007-03-31
    End date: 2007-04-02

Lasix
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Oedema
    Start date: 2007-04-05

Levofloxacin
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2007-03-29
    End date: 2007-03-31

Omegacin
    Dosage: 300 mg, unk
    Indication: Pyrexia
    Start date: 2007-03-27
    End date: 2007-04-02

Vancomycin
    Dosage: 1.5 g/day
    Indication: Pyrexia
    Start date: 2007-03-31
    End date: 2007-03-31

Other drugs received by patient: Epogen; Humulin 70 / 30; Firstcin; Ferromia

Adverse event in 79 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-07-09

Patient: 79 year old male

Adverse reactions / side effects: Blood Bilirubin Increased, Pyrexia, Liver Disorder, Malaise, Haematocrit Decreased, RED Blood Cell Count Decreased, Gamma-Glutamyltransferase Increased, White Blood Cell Count Increased, Blood Glucose Increased, Lymphocyte Count Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Pneumonia, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Diovan (Valsartan)

Other drugs received by patient: Lendormin; Pariet; Norvasc; Rinderon; Aspirin; Clarithromycin; Rizaben

Adverse event in 82 year old female receiving Diovan (Valsartan)

Reported by a individual with unspecified qualification from Japan on 2007-07-02

Patient: 82 year old female, weighing 56.0 kg (123.2 pounds)

Adverse reactions / side effects: Hyperkalaemia, Feeling Cold, Blood Pressure Inadequately Controlled, Sinus Arrest, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Ventricular Extrasystoles, Blood Urea Increased, Muscular Weakness, Blood Potassium Increased, Blood Bicarbonate Decreased, Computerised Tomogram Abnormal, Tremor, Haemodialysis, Haemoglobin Decreased, Anorexia, Renal Hypertension, Electrocardiogram Abnormal, Bradycardia, Gait Disturbance, Blood Pressure Decreased, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aldactone
    Dosage: 25 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-11-18
    End date: 2003-01-06

Diovan
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-12-01

Diovan
Start date: 2002-12-12
End date: 2003-01-06

Landel
    Dosage: 60 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2001-02-27
    End date: 2003-01-06

Landel
    Dosage: 20 mg/day
    Administration route: Oral
    Start date: 2003-01-10

Odrik
    Dosage: 2 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 1997-11-06
    End date: 2003-01-06

Pimenol
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Ventricular Arrhythmia
    Start date: 1997-11-06
    End date: 2003-01-06

Salobel
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 1997-02-25
    End date: 2003-01-06

Spironolactone
    Dosage: unk, unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-11-01

Trandolapril
    Administration route: Oral
    Indication: Hypertension
    Start date: 1982-01-01

Adverse event in 80 year old male receiving Diovan (Valsartan)

Reported by a physician from Japan on 2007-06-28